Regulatory Intelligence as the Basis for Regulatory Strategy and Global Drug Development

Nonfiction, Health & Well Being, Health
Cover of the book Regulatory Intelligence as the Basis for Regulatory Strategy and Global Drug Development by Petra Heyen, GRIN Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Petra Heyen ISBN: 9783638372015
Publisher: GRIN Publishing Publication: April 28, 2005
Imprint: GRIN Publishing Language: English
Author: Petra Heyen
ISBN: 9783638372015
Publisher: GRIN Publishing
Publication: April 28, 2005
Imprint: GRIN Publishing
Language: English

Master's Thesis from the year 2004 in the subject Health Science, grade: sehr gut, University of Bonn (Mathematisch-Naturwissenschaftliche Fakultät), 24 entries in the bibliography, language: English, abstract: The Regulatory Affairs (RA) department is a key discipline in the global network of drug development. During drug development, regulatory strategy is one crucial success factor for the approval of the development candidate. Also, regulatory strategy can optimise labelling in the key countries in order to maximise the market success. No submission and approval would be possible without the appropriate dossier composition and compilation. Without adherence to the respective guidance documents and scientific advice from Health Authorities to design the optimal clinical development plan, optimal labelling would not be feasible. These two examples show some characteristics of the regulatory strategy: it is highly interactive with other disciplines and it is heavily based on a thorough intelligence work which enables the RA Manager to know the 'rules of the game' and to develop the optimal regulatory strategy for the current development candidate. The major cornerstone for developing a regulatory strategy is regulatory intelligence. This document focuses on regulatory intelligence. The regulatory contributions to the global drug development from early research to submission are described. Strategies for generic drugs as well as detailed strategies for life-cycle management are excluded. Major components of regulatory intelligence are: •Competitor Information •Information on Regulatory Environment •Information on Legal Requirements Competitor analysis is an essential aspect of the intelligence work. Sources of competitive information as well as relevant items of competitive information are described. Sources of information about the regulatory environment and sources of information about the legal regulatory environment are described and their tremendous impact on setting up and modifying the regulatory strategy evaluated. Special attention is paid to the components and sources of regulatory intelligence information (e.g. Internet links and documents related to intelligence information). Some examples show how regulatory intelligence information supports the regulatory strategic considerations. The last section describes the regulatory strategy itself and examples of how regulatory intelligence acts as the basis for setting up the regulatory strategy. What is the basis of strategic considerations, what are the considerations, what are the major components of a regulatory strategy, how do the different disciplines involved in drug development work together?

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Master's Thesis from the year 2004 in the subject Health Science, grade: sehr gut, University of Bonn (Mathematisch-Naturwissenschaftliche Fakultät), 24 entries in the bibliography, language: English, abstract: The Regulatory Affairs (RA) department is a key discipline in the global network of drug development. During drug development, regulatory strategy is one crucial success factor for the approval of the development candidate. Also, regulatory strategy can optimise labelling in the key countries in order to maximise the market success. No submission and approval would be possible without the appropriate dossier composition and compilation. Without adherence to the respective guidance documents and scientific advice from Health Authorities to design the optimal clinical development plan, optimal labelling would not be feasible. These two examples show some characteristics of the regulatory strategy: it is highly interactive with other disciplines and it is heavily based on a thorough intelligence work which enables the RA Manager to know the 'rules of the game' and to develop the optimal regulatory strategy for the current development candidate. The major cornerstone for developing a regulatory strategy is regulatory intelligence. This document focuses on regulatory intelligence. The regulatory contributions to the global drug development from early research to submission are described. Strategies for generic drugs as well as detailed strategies for life-cycle management are excluded. Major components of regulatory intelligence are: •Competitor Information •Information on Regulatory Environment •Information on Legal Requirements Competitor analysis is an essential aspect of the intelligence work. Sources of competitive information as well as relevant items of competitive information are described. Sources of information about the regulatory environment and sources of information about the legal regulatory environment are described and their tremendous impact on setting up and modifying the regulatory strategy evaluated. Special attention is paid to the components and sources of regulatory intelligence information (e.g. Internet links and documents related to intelligence information). Some examples show how regulatory intelligence information supports the regulatory strategic considerations. The last section describes the regulatory strategy itself and examples of how regulatory intelligence acts as the basis for setting up the regulatory strategy. What is the basis of strategic considerations, what are the considerations, what are the major components of a regulatory strategy, how do the different disciplines involved in drug development work together?

More books from GRIN Publishing

Cover of the book Key features of network sociality and critical assessment of the notion of a 'networked society' by Petra Heyen
Cover of the book Managing cultural differences between UK and China by Petra Heyen
Cover of the book Effect of maternal employment on children's home and emotional adjustment by Petra Heyen
Cover of the book Porträtmalerei - Die Problematik des Ehepaarbildnis by Petra Heyen
Cover of the book Review on use of Reinforcement Learning in Artificial Intelligence by Petra Heyen
Cover of the book The Impact of Technology on Marketing Strategy by Petra Heyen
Cover of the book Corporate Social Responsibility of Fraport AG by Petra Heyen
Cover of the book A novel and its adaptation: Stanley Kubrick: Lolita (1962) by Petra Heyen
Cover of the book Critically examine the factors that have contributed to nationalism and xenophobia in Germany after reunification by Petra Heyen
Cover of the book Customer Loyalty by Petra Heyen
Cover of the book The modern theories of international relations - old thoughts or innovative ideas? Investigation of Constructivism and Critical Theory by the three Traditions of Martin Wight by Petra Heyen
Cover of the book An examination of the extent to which Rousseau reconciled the claims of the individual and the community by Petra Heyen
Cover of the book The haunted wilderness as the Sublime in Canadian Gothic fiction in the 19th century by Petra Heyen
Cover of the book The struggle to find a definition for 'international terrorism' by Petra Heyen
Cover of the book The Ryan Air Model - Success and Impact on the European Aviation Market by Petra Heyen
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy